Reflex human papillomavirus DNA testing on residual liquid-based (TPPT™) cervical samples: Focus on age-stratified clinical performance

Cancer

Volumn 99, Issue 3, 2003, Pages 149-155

  Sarode, Venetia Rumnong ^a   Werner, Claudia ^a   Gander, Rita ^a   Foster, Barbara ^b   Fulmer, Amy ^a   Saboorian, M Hossein ^a   Ashfaq, Raheela ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Age and race; Atypical squamous cells of undetermined significance (ASCUS); Human papillomavirus (HPV); Hybrid capture (HC II); Liquid based; Routine ThinPrep testing (TPPT); Triage

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTODIAGNOSIS; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DNA DETERMINATION; ETHNOLOGY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; LIQUID BASED CYTOLOGY; MAJOR CLINICAL STUDY; PERFORMANCE; PRIORITY JOURNAL; SQUAMOUS CELL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CYTOLOGY; VALIDATION PROCESS; WART VIRUS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CERVIX UTERI; CHEMILUMINESCENT MEASUREMENTS; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; PAPILLOMAVIRIDAE; VAGINAL SMEARS;

EID: 0038458967     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11190     Document Type: Article

References (25)

1. Cox JT, Lorincz AT, Schiffman MH, et al. Human papillomavirus testing by hybrid capture appears to be useful in tri-aging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 1995;172:946-954.
2. Ferenczy A, Franco E, Arseneau J, Wright TC, Richart R. Diagnostic performance of hybrid capture human papillomavirus DNA assay combined with liquid-based cytologic study. Am J Obstet Gynecol. 1996;175:651-665.
3. Ferris DG, Wright TC Jr., Litaker MS, et al. Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL. J Fam Pract. 1998;46:136-141.
4. Clavel C, Masure M, Bory J-P, et al. Hybrid Capture II-based HPV detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women. Br J Cancer. 1999;80:1306-1311.
5. Manos MM, Kinney WK, Hurley LB, et al. Identifying women with cervical neoplasia using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA. 1999;281:1605-1610.
6. Rebello G, Hallam N, Smart G, Farquharson D, McCafferty J. Human papillomavirus testing and the management of women with mildly abnormal cervical smears: an observational study. BMJ. 2001;322:893-894.
7. Schiffman M, Herrero R, Hildeschein A, et al. HPV DNA testing in cervical cancer screening: results from a high-risk province in Costa Rica. JAMA. 2000;283:87-93.
8. Solomon D, Schiffman M, Tarone B, for the ALTS group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance (ASCUS): baseline results from a randomized trial. J Natl Cancer Inst. 2001;93:293-299.
9. Cox JT. Evaluating the role of HPV testing for women with equivocal Papanicolaou test findings. JAMA. 1999;281:1645-1647.
10. Cuzick J. Human papillomavirus testing for primary cervical cancer screening. JAMA. 2000;283:108-109.
11. Schlay JC, Dunn T, Byers T, Baron AE, Douglas JM. Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on papanicolaou smears. Obstet Gynecol. 2000;96:410-416.
12. Wright TC Jr., Lorincz A, Ferris D, Richart R, et al. Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears. Am J Obstet Gynecol. 1998;178:962-966.
13. Cuzick J, Beverly E, Ho L, et al. HPV testing in primary screening of older women. Br J Cancer. 1999;81:554-558.
14. Ho GYY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal Papillomavirus infection in young women. N Engl J Med. 1998;338:423-428.
15. Stoler MH. Human Papillomavirus and cervical neoplasia: a model for carcinogenesis. Int J Gynecol Pathol. 2000;19:16-28.
16. Sherman ME, Mendoza M, Lee KR, et al. Performance of liquid-based, thin-layer cervical cytology: correlation with reference diagnoses and human papillomavirus testing. Mod Pathol. 1998;11:837-843.
17. The ALTS Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst. 2000;92:397-402.
18. Zar JH. Biostatical analysis, 4th edition. Upper Saddle River, NJ: Prentice Hall, 1999:564.
19. Bergeron C, Jeannel D, Poveda J-D, Cassonnet P, Orth G. Human papillomavirus testing in women with mild cytologic atypia. Obstet Gynecol. 2000;95:821-827.
20. Kinney WK, Manos MM, Hurley LB, Ransley JE. Where's the high-grade cervical neoplasia?: the importance of minimally-abnormal Papanicolaou diagnoses. Obstet Gynecol. 1998; 91:973-976.
21. Herbst AL, Pickett KE, Follen M, Noller KL. The management of ASCUS cervical cytologic abnormalities and HPV testing: a cautionary note. Obstet Gynecol. 2001;98:849-851.
22. Chesebro MJ, Everett WD, Lorincz A. High-risk human papillomavirus testing of women with cytological low-grade squamous intraepithelial lesions. J Low Gen Tract Dis. 1997; 1:234-239.
23. Manos MM. HPV testing for clarifying borderline cervical smear results. BMJ. 2001;322:878-879.
24. Pirog EC, Baergen RN, Soslow RA, et al. Diagnostic accuracy of cervical low-grade squamous intraepithelial lesions is improved with MIB-1 immunostaining. Am J Surg Pathol. 2002;26(1):70-75.
25. Woodman CBJ, Collins S, Winter H, Bailey A, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet. 2001;357:1831-1836.